Combination Study of Capecitabine and Erlotinib Concurrent With Radiotherapy for Non-Operable Advanced Pancreatic Cancer

The recruitment status of this study is unknown because the information has not been verified recently.
Verified November 2012 by Penn State University.
Recruitment status was  Active, not recruiting
Genentech, Inc.
Information provided by (Responsible Party):
Yixing Jiang, Penn State University Identifier:
First received: November 29, 2007
Last updated: November 30, 2012
Last verified: November 2012
No Study Results Posted on for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2013
  Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)